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INTRODUCTION 
Until 1995 central and eastern Europe as well as the Asian republics of the former 
Soviet Union have been more-or-less devoid of epidemic outbreaks of HIV infection. In this 
region with more than 450 million inhabitants (United Nations 1997), the total number of 
HIV infections was estimated lower than 30.000 (WHO 1995; UNAIDS 1996). Most of these 
infections resulted from sexual and nosocomial transmission. In 1995 this epidemiologically 
soporific picture started changing drastically in two ways. Firstly, reports on rapid HIV 
outbreaks in various parts of the former Soviet Union started to surface, and, secondly, these 
new infections were almost exclusively associated with another major public health crisis that 
until then had gone largely unnoticed: the rapid diffusion of drug injecting. Indeed, the social 
networks of drug injectors have provided an almost custom-tailored infrastructure for the 
virus to spread through the former Soviet Union and most HIV cases are reportedly related to 
illicit drug injecting. Except for Poland and Yugoslavia, the countries in central and southeast 
Europe have not yet experienced epidemic HIV spread, although in many of these countries 
drug injecting has become a major public health concern as well.  
At the end of the year 2000, there were an estimated 700,000 people living with HIV 
in this region; 250,000 of them acquired the virus in the new millennium. Most of these 
infections are among injecting drug users (UNAIDS/WHO 2000a). This chapter will provide 
an overview of the development of the epidemic in the region and discuss some of its 
epidemiological and social peculiarities. Subsequently, it will bring to the reader’s attention 
some of the social and political impediments to developing appropriate responses, which are 
rooted in its recent totalitarian past and exacerbated by the “backdrop of social-economic 
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turmoil” (UNAIDS/WHO 2000b) that characterizes the post-communist transition process. 
Next, it will discuss the human rights aspects of the, for this epidemic so important, drugs-
AIDS nexus, as well as its link to another historically unsettling feature of this region: its 
traditionally abysmal treatment of ethnic minorities, in particular the stateless Roma. To 
counter some of the pessimism these issues may have elicited in the reader, the chapter ends 
with a—given the immensity of the region, inevitably partial—description of interventions 
that nevertheless have developed.  
 
ISSUES RELATING TO HIV AND AIDS 
History of HIV/AIDS 
It was in 1995 that the first reports appeared on outbreaks of HIV in different parts of 
the former Soviet Union, including the Black Sea ports Odessa and Nikolayev, the 
northwestern Russian enclave of Kaliningrad (a seaport as well), and Svetlogorsk in southern 
Belarus. Only separated by months, epidemics developed in these three countries with highly 
similar features. 
 In Ukraine less than 100 HIV infections were registered between 1988 and 1994, 
which concerned mainly foreigners. However, in March and April 1995 more than 1000 
cases were detected among drug injectors in Odessa and Nikolayev, after the militia was 
instructed to round up registered drug users for testing. HIV prevalence among drug injectors 
arrested by the militia or in contact with narcology centersi  grew rapidly from virtually zero 
to 31% Odessa and 57% in Nikolayev (Khodakevich 1997). Within a year HIV infections 
were reported among drug injectors from all 25 regional capitals and more recent reports 
suggest continued spread into rural areas and cities in the eastern and central parts of the 
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country (UNAIDS 2000a). Countrywide, the registered number of new HIV infections rose to 
1490 in 1995, up from 31 in the year before.  An additional 5400 new cases were registered 
in 1996, and this number peaked at 8913 in the following year.  A total of 8575 new 
infections were registered in 1998 and 5827 in 1999, resulting in a cumulative total of 30,388 
reported cases at the end of 1999 (WHO-EURO 2000). At the end of 1999, UNAIDS 
estimated the number of HIV-positive people in Ukraine at 240,000, and between 50 and 
80% are associated with injecting drug use (UNAIDS 2000a). 
 Fewer than 1100 HIV cases were registered in the Russian Federation between the 
start of registration in 1987 and the end of 1995. Among these cases were very few injecting 
drug users (IDUs) (Pokrovskyi et al. 1997). Kaliningrad first reported a rapidly escalating 
number of infections among drug injectors, but the outbreak was not contained to this East 
Sea enclave. In 1996 and 1997 cities all over the Russian map, including Krasnodar, Nizhnyi 
Novgorod, Rostov Na Donu, Saratov, Tula, Tumen and Tver, reported epidemic spread 
among IDUs as well (Pokrovskyi et al. 1998; Burrows et al. 1998). In early 1999 the 
epidemic hit the federal capital. One year later (June 2000 data), Moscow has officially 
registered 6670 HIV infections and an additional 8904 infections in the surrounding Moscow 
oblast (administrative region). With 782 and 222 officially registered HIV cases, St. 
Petersburg and its surrounding oblast Leningrad still seem to lag behind (Ministry of Health 
of the Russian Federation 2000). However, a 1999 survey among IDUs in St. Petersburg 
found that HIV prevalence rates rose in six months from 12% to 19% (UNAIDS 2000b). To 
appreciate the epidemic’s geographical dimension, the remote city of Irkutsk has already 
registered 5773 cases (Ministry of Health of the Russian Federation 2000). At the end of 
2000 the epidemic has spread to over 30 cities across Russia and 82 out of 89 oblasts had 
reported HIV cases (UNAIDS/WHO 2000b). 
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 Overall, the number of registered new cases in Russia increased from 196 in 1995, to 
1546 in 1996 and 4399 in 1997. During 1998 new cases decreased to 3947, but the following 
year they jumped to 19,661. More than 90% of new cases in 1998 and 1999 were registered 
among injecting drug users. The average age of HIV infected individuals was 18 to 25 years. 
Nine HIV positive cases concerned 11 to 14 year-olds who became infected through injecting 
drug use. With 15,696 new cases in the first half year, the 2000 incidence is projected to 
supercede the total prevalence of 1999 (30,624 cases) (Ministry of Health of the Russian 
Federation 2000), and to climb to 50,000 by year’s end (UNAIDS/WHO 2000a). At the start 
of 2000, UNAIDS estimated the number of HIV-positive people in the Russian Federation at 
130,000 (UNAIDS 2000c). At the end of the year this figure will have climbed to 300,000 
(UNAIDS/WHO 2000b). Close to 90% of cases are associated with injecting drug use. 
 In the beginning of 1996 the first case of HIV in an IDU since 1992 was established 
in Minsk, the capital of Belarus. This case concerned a resident of Svetlogorsk, a town of 
72,000 in the southern Gomel oblast. Subsequent mass screening (targeting known drug 
users) revealed 1125 HIV infections, 88% among drug injectors (Bezruchenko-Novachuk and 
Romantsov 1998). In 1997 an HIV prevalence of 67% was found in blood samples drawn 
from the syringes of participants of the Svetlogorsk needle exchange (Bezruchenko-
Novachuk and Romantsov 1998). That same year, HIV was detected among IDUs in all 
oblasts of Belarus. The number of registered new cases in Belarus increased from 8 in 1995, 
to 1021 in 1996, but fell to 653 in 1997 and continued to decrease to 554 and 411 in the 
subsequent two years (WHO-EURO 2000). At the end of 1999, there were 2752 cases of HIV 
infection registered in Belarus (WHO-EURO 2000), but UNAIDS estimated the number of 
HIV-positive people at 14,000 at the end of 1999 and more than 80% are associated with 
injecting drug use (UNAIDS 2000d). 
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 Moldova experienced an outbreak of HIV soon after Ukraine, Belarus and Russia, but 
hitherto the number of cases remained lower. Registered new cases rose from 7 in 1995 to 48 
in 1996 and further to 404 and 408 in the subsequent two years, but fell to 155 in 1999 
(WHO-EURO 2000). A total of 1034 cases of HIV infection were registered in Moldova at 
the end of 1999 (WHO-EURO 2000), but according to UNAIDS the number of HIV-positive 
people was 4500. Most infections have been detected in the two major cities Chisinau and 
Baltsi, and more than 80% are associated with injecting drug use (UNAIDS 2000e). 
 More recently HIV has diffused into populations of IDUs in the Baltic states as well, 
most notably in Latvia where in 1998 the number of new cases jumped to 163, up from 25 in 
the previous year, while 241 new cases were registered in 1999. At the end of 1998, 122 
cases were registered among IDUs (WHO-EURO 2000). These numbers may not seem 
dramatic, but they put Latvia among the three countries in the entire (WHO) European region 
with incidence rates (per million population) over 100 in 1999, the other two being Russia 
and Ukraine. After initial reports on outbreaks among IDUs in its port city Klaipeda, 
Lithuania seems to have been able to contain epidemic spread. At the end of 1998, 66 cases 
had been registered among IDUs (WHO-EURO 2000). But in 2000, a new epidemic emerged 
among drug injectors in Narva, Estonia, with the result that the country reported far more 
HIV cases than in any previous year (UNAIDS/WHO 2000a). In the three Caucasus republics 
Armenia, Azerbaijan and Georgia the number of infections is also on the rise. Although in a 
large number of registered HIV cases in this subregion the transmission category was 
unknown (e.g. prisoners or military personnel who may have injected drugs), most of these 
infections are associated with injecting drug use as well (WHO-EURO 2000). Central Asia 
has remained largely untouched by the global AIDS pandemic, but in 1999 HIV infections 
were reported among IDUs in four of the five countries. Furthermore, the detention-related 
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outbreak of HIV among IDUs in Temirtau, in the Karaganda oblast of Kazakhstan 
demonstrates that this subregion is not immune to rapid epidemic spread. Prior to the 
detection of HIV among drug users imprisoned in the local prison, there were just 69 
registered cases of HIV in Kazakhstan. Since then, testing of drug users has been intensified. 
As a result, 736 new cases were reported between 1997 and 1998, 88% among injecting drug 
users (UNAIDS 2000f). 
 Most former communist countries in central Europe have thus far not reported 
epidemic spread of HIV, except for Poland. While homosexual and bisexual men in the 
region are the most affected population group, overall reported prevalence remained 
relatively low. Nonetheless, Poland was hit by an outbreak among drug injectors in the late 
1980s. The numbers of reported infections among IDUs jumped from one in 1988 to 411 in 
1989 and since 1995 between 539 and 638 new infections are registered yearly (WHO-EURO 
2000). The majority of those are associated with injecting drug use (UNAIDS 2000g). At the 
end of 1999 the cumulative total reported cases in Poland was 6118 (WHO-EURO 2000), but 
UNAIDS estimates the total number of HIV positive people at 13,000 (UNAIDS 2000g). As 
in central Europe, HIV infections among injecting drug users in the Balkan countries have 
remained low, except in Yugoslavia (Serbia and Montenegro) which experienced an early 
IDU-driven epidemic similar to Poland. Most other countries in this sub-region primarily 
reported heterosexual transmission, but transmission between MSM is likely to be 
underreported because of strong stigmatization. Assessment of the levels of HIV and 
injecting drug use in southeastern Europe are severely hampered by the recent political events 
in the region. 
 All in all, both in central and southeastern Europe the preconditions exist for epidemic 
outbreaks of HIV infection among IDUs. While IDU populations are perhaps still smaller 
A Candle Lit from Both Sides Page 9 
 
than in several of the Newly Independent States (NIS), a growing number of authors have 
suggested that drug injecting is on the increase throughout both subregions (Grund and 
Nolimal 1995; Honti and Zelenai 1999; Khodakevich and Dehne 1998; Nolimal and Jerman 
1996; Polanecky et al. 1996). Likewise, anecdotal reports suggest high prevalence of hepatitis 
C among IDUs in many parts of these two subregions.  
 
Data Collection Issues 
In most countries in this large region—almost 30 countries between Germany’s 
eastern border and the Pacific ocean, stretching 11 time zones—HIV reporting is based on 
mandatory mass screening and a two-stage registration process, introduced in 1987. 
Reporting of HIV/AIDS cases is required by law and MoH regulations. Screening targets 
include both low risk (e.g. pregnant women, blood donors, occupational groups) and 
vulnerable populations (drug users, prisoners, STD patients). For years millions of dollars 
have been invested in this costly but inefficient pursuit—in 1995 approximately 95% of the 
Ukrainian HIV/AIDS budget was spend on testing kits: that same year the epidemic struck 
the country’s IDU networks.  
 Testing policies for low risk populations have become less stringent since the early 
1990s. Officially, most HIV tests are now voluntary, except for blood donors and foreigners 
(e.g. in Russia). Yet, routine mandatory screening without informed consent and pre- and 
post-test counseling of high risk populations, including identified drug users, prisoners and 
STD patients remains a routine exercise throughout the region. Since 1999-2000, innovative 
methods of HIV surveillance (e.g. sentinel surveillance) are being slowly implemented in a 
few countries but officially these are not yet included in the national guidelines on HIV 
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monitoring (Y. Kobyshcha, personal communication). Voluntary, confidential, or anonymous 
testing accounts for only a fraction of both tests and positive results registered. This pattern is 
perhaps associated with the fact that the anonymity of people testing HIV positive is often not 
upheld. 
 Registration includes the recording of all test results and the referral of positive results 
to an AIDS center for confirmation, history taking, official registration, and treatment (when 
available). Classification (and reclassification of e.g., prisoners) into transmission category is 
based on the clinic interview. In most countries reporting is based on the registration of the 
AIDS centers. Because of intense stigmatization and potentially serious consequences (from 
losing one’s employment or driver’s license to imprisonment and ongoing police harassment, 
including unlawful entry of the home) many people are unwilling to disclose a history of drug 
use.  
 
Furthermore, incomplete referrals between the initial test site and the health institution 
responsible for registration have resulted both in underreporting and biased distributions over 
transmission categories. For example in Ukraine, each person with a confirmed HIV positive 
test result is obliged to attend an AIDS Center or other specialized infectious diseases clinic 
for extensive clinical and biological examinations, which must be completed before official 
registration. But in practice a large number of people found HIV positive after laboratory 
testing (mainly drug users) do not show up for further examination at these clinics, resulting 
in delays in reporting and considerable under-reporting. Thus, during the first years of the 
epidemic (1996-1997) only 50% of people with HIV positive test results were officially 
registered (Y. Kobyshcha, personal communication). Likewise, Russian data for 1996 and 
1997 included more than 2000 cases for which the transmission mode was unknown. The 
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HIV data presented in this section are therefore in all likelihood an underestimate of the true 
dimensions of the HIV epidemic in this region.  
 
Colliding Epidemics: HIV and Injecting Drug Use 
Research in diverse regions of the world has established rapid HIV spread associated 
with transmission among IDUs (Angarano et al. 1985; Ball et al. 1998; Hamers et al. 1997; 
Ismail 1998; Rebagliato et al. 1995; Stimson 1994; Zheng et al. 1994), sometimes resulting in 
increases of HIV prevalence among drug injectors from less than 5% to 30 to 50% in one to 
three years (Burns et al. 1996; Crofts et al.1998; Des Jarlais et al. 1994; Htoon et al. 1994; 
Stimson 1994; Weniger et al. 1991). Khodakevich (1997) reported equally rapid HIV spread 
in Svetlogorsk, Belarus, and Odessa and Nikolayev in Ukraine. By mid-1999 HIV 
transmission among IDUs was reported from 114 countries and in many countries injecting 
drug use has been the main mode of transmission (UNAIDS 2000h). However, in no other 
region the overall proportion of reported cases associated with drug injecting is as high as in 
eastern Europe, in particular in the NIS. In this section we will discuss some of the factors 
that may be associated with this issue. This discussion will concentrate on the countries of the 
former Soviet Union as those are hit hardest by the HIV epidemic. 
 While certainly not unknown before the breakdown of communism, drug use seems to 
have rapidly increased in the 1990s. Officially registered injecting drug users in Ukraine rose 
from around 20,000 in the early 1990 to 80,000 in 1997 (Dehne et al. 1999). According to the 
Russian ministry of internal affairs the number of people undergoing drug treatment was 
249,000 in 1996, up from 91,000 two years earlier (Khodakevich and Dehne 1998). The 
country’s ministry of health reported a more modest increase: from 25,000 in 1990 to 85,000 
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in 1996 (Khodakevich and Dehne 1998). Such a discrepancy illustrates the unreliability of 
these statistics. Before the political changes in the Soviet Union drug use was officially non-
existent and consequently not enumerated. In reality drug users were persecuted 
indiscriminately by militia, sentenced to many years in prison, committed to inhumane 
mandatory treatment and other repressive measures. Nowadays these practices still prevail in 
many parts of the region with the result that people who use drugs avoid contact with drug 
treatment and other health institutions as much as possible. As a consequence, the official 
number of registered drug users is only a small proportion of the real size of the drug user 
population.  
 
In 1997 the Ukrainian ministry of internal affairs estimated the total number of drug 
users between 600,000 and 700,000 and IDUs represented 75% to 80% of these cases 
(Khodakevich and Dehne 1998). Estimates in Russia range from 600,000 to one or two and a 
half million (Brunet 1996; USAID and Centers for Disease Control and Prevention 1998). 
While their reliability is difficult to assess, these estimates suggest that in both countries more 
than 1% of the population is involved in drug use. “Rapid Situation Assessments” (WHO 
1998) in a number of Russian cities estimate the number of IDUs at 35,000 for Nizhniy 
Novgorod, 9,500 to 10,000 in Rostov Na Donu, 70,000 in St. Petersburg and 18,000 in 
Volgograd. The author’s fieldwork in these cities during 1999 suggests that the use of 
injectable opiates in particular has become a regular feature of the social ecology of many 
neighborhoods in these cities. As one outreach worker in Volgograd explained, “People drink 
or inject in this place.” Likewise, an epidemiologist in Rostov Na Donu thought that “it [was] 
difficult to find a building in this town that is not affected by drug use.”  
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 While more recently the use of (imported) heroin has increased drastically in many 
cities, drug use patterns throughout the NIS are characterized by two rather specific 
observations, which add dramatically to the potential for drug related harm. First, the 
tradition of kitchen production of alcoholic beverages seems to have been extended to a 
number of other psychoactive substances. Simple ‘bathtub chemistry’ is used to process 
opium poppies into a strong injectable opioid cocktail, and ephedrine-based medications into 
methamphetamine and methcathinone, both powerful psychostimulants. Second, there seems 
to be a prevailing perception among a majority of drug users that, perhaps apart from 
cannabis, drugs are to be injected. Thus, while in the USA snorting Ketamine (a dissociative 
anesthetic primarily used in veterinary medicine) has gained considerable popularity in gay 
dance clubs, in Russia this drug is primarily injected among straight middle class youth. The 
self-produced opioids and amphetamines are generally prepared for injection as well.  
 Many risk behaviors identified in drug injecting-related HIV epidemics elsewhere are 
relevant to the reported rapid spread. For example, sequential use (sharing) of syringes and 
needles has been reported from many cities throughout the region, including Moscow, St. 
Petersburg, Kaliningrad, Nizhniy Novgorod, Rostov Na Donu, Volgograd and Pskov in 
Russia, Poltava and Odessa in Ukraine, Svetlogorsk in Belarus, Almaty and other cities in 
Kazakhstan, and Tblisi in Georgia. In a recent study of syringe exchange participants in five 
Russian cities, 38% (N=1076) of the participants admitted that in the 30 days before they 
joined the program they had injected with a syringe that was previously used by someone else 
(Grund et al. 2001).  
 However, a number of region-specific risk factors can be identified, associated to the 
home preparation of injectable drugs, in particular opiates. Using water and common 
household chemicals, including ethyl acetate, soda vinegar and acetic anhydride, IDUs boil 
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opium poppies or opium gum into a strong injectable cocktail of opioid alkaloids (containing, 
codeine, morphine and heroin in varying proportions). The resulting cocktail is known under 
a number of different names in the region, including Cheornaya (black), Chemia or Himya 
(chemistry), Mak, Shirka and Hanka.  
 A number of authors have wondered whether HIV might be introduced into the 
mixture during the production process through the use of contaminated mixing containers. 
Others hypothesized that the (nowadays rare) practice of using blood to filter solid particles 
from the solution might have caused rapid outbreaks of HIV in several Russian and Ukrainian 
cities (Bolekham and Zmushko 1998; Liitsola et al. 1998; Lukashov et al. 1998). However, 
recent ethnographic observations of the production process in Russia (Grund et al. 2001; 
Dehne et al 1999) and laboratory simulations of the process (Heimer, personal 
communication) show that contamination of the drug solution during the production process 
is extremely unlikely. Even when contaminated blood is used, the solution is subsequently 
repeatedly boiled for extended periods and at the end of the process acetic anhydride (a 
highly caustic chemical) is added. (For a description of the process and its potential for HIV 
transmission, see Dehne et al. 1999.) 
 A perhaps more plausible hypothesis is related to how the practice of self-production 
has shaped the drug culture (Grund 1998a) in this region. A typical feature of the self-
production and use of opiates is that is it mostly conducted within groups of two or more 
people and when the drugs are ready for consumption they are divided by squirting them 
from one (large) syringe into those of the group members. This technique—termed 
“Frontloading” or “Syringe-Mediated-Drug-Sharing” (SMDS)—has been described in many 
other parts of the world and is associated with HIV seroconversion (Grund et al. 1991; Grund 
et al. 1996; Jose et al. 1993). The regular practice of preparing and using in groups is also 
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likely to result in higher frequencies of needle sharing, than in more individualistic cultures 
of drug injecting. Nevertheless, a recent study of syringe exchange participants in five 
Russian cities indicated that while syringe sharing decreased substantially (from 38 to 11%) 
after respondents joined the exchange program, several behaviors associated with the context 
of group drug use decreased to a much lesser degree. The practice of injecting with friends 
itself was hardly affected by participation in the needle exchange program, going from 91% 
before, to only 86% after joining the program. Likewise, sharing drug paraphernalia other 
then needles and syringes only went down from 82% to 73%, while SMDS decreased only 
from 58% to 48% (Grund et al. 2001). 
 
Thus, the social context of drug injecting, especially the seemingly ubiquitous 
practice of preparing and using drugs in groups may well be responsible to a large extent for 
the rapid diffusion of HIV among the IDU populations in the region. Many questions arise 
from this hypothesis—for example, concerning the density and connectivity of IDU 
networks. Nevertheless, home production and its communal aspects in particular may well 
produce considerably higher rates of established risk behaviors than in more individualistic 
drug injecting cultures where (imported) powder drugs are used.  
 In summary, the circumstances under which HIV is transmitted among IDUs in the 
region is at present insufficiently understood. This situation is in urgent need of thorough 
ethnographic and epidemiological study. Not only is it essential to gain a better understanding 
of transmission among IDUs themselves, but research should also address the questions of 
the potential and mechanisms of secondary spread into non-IDU populations. At the 
presentation of the December 2000 AIDS epidemic update, WHO’s director general, Dr. Gro 
Harlem Brundtland, warned that “in just three to four years, Russia may well have a 
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generalized epidemic” (UNAIDS/WHO 2000b). Elsewhere Dehne and colleagues (1999) 
reviewed this hazard and hypothesized that the overlap between drug injecting and sex work 
could well become the critical link in the epidemiological chain between the current HIV 
epidemics among IDUs and a generalized epidemic. Another scenario might be based on the 
sheer magnitude of the fast-paced, post-communist epidemic of drug injecting in central and 
eastern Europe and the FSU and its apparent normalcy in many communities.  
 Although reliable statistics are lacking, injecting drug use appears to have touched a 
significant proportion of the population in the region. Drug injectors may be subject to 
intense state repression, but they appear to remain fairly well integrated in family structures 
and social networks that are not necessarily built around drug-related activities (Grund 
unpublished data). Likewise, self-injection does not always seem to invoke the same level of 
stigmatization known in western Europe or the USA, and is, reportedly a commonly accepted 
method of taking both medical and recreational drugs in parts of the region (de Jong et al. 
1999). When the stigma against drug injecting is limited, and when IDUs spend relatively 
more time in “non-drug” networks, they are likely to meet more sexual partners who do not 
inject drugs, than when they only socialize with other drug users. Ergo, the widespread 
practice of drug injecting may provide for many links in the epidemiological chain towards a 
generalized epidemic, that will be unprecedented in the northern hemisphere.  
 
Obstacles to controlling the HIV/AIDS epidemics in the region 
The common denominator of this region is that all countries are undergoing a 
transition process from closed societies with state-controlled economies towards more 
democratic, open societies with free market economies—until now, with various results. For 
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most people the transition includes a significant drop in the quality of life, set against a 
background of profound social and political change. For many citizens, unemployment and 
decreased access to housing, health care and social services have been the price for economic 
and political liberalization. Where formal economies stagnate, informal economies have 
mushroomed and organized crime is growing rapidly. Increasingly, illicit drugs are becoming 
a prime commodity within this “shadow economy.” The region’s transition process, its 
communist legacy, and the associated economic crises in many parts of the region can be 
seen to hamper the response to the HIV epidemic in many ways.  
 In most, if not all, of the NIS countries that experienced significant HIV outbreaks 
among IDUs, appropriate governmental responses only developed after these outbreaks were 
firmly established, despite the writings on the wall. Instead of timely introducing public 
health-based HIV prevention programs targeting IDUs, governments relied on outmoded and 
ineffective mass screening procedures and police repression of drug users. What's more, most 
of the (central European) countries that have been spared epidemic HIV spread so far seem 
bound to repeat this mistake, as funding levels for needle exchange and other HIV prevention 
activities targeting IDUs are, generally speaking, grossly inadequate. In fact, most needle 
exchange programs in the region exist on foreign funding.  
 One of the most important lessons in this epidemic is that successful responses require 
“multisectoral and multilevel” approaches (UNAIDS 2000h). However, such thinking does 
not tie in well with the bureaucratic legacy of the communist era we find in many, if not most 
countries in the region. The Soviet approach to management was strictly hierarchical and 
multi-layered, and in many places few structural changes have taken place in the 
bureaucracy. Governmental health structures are extremely complex and frequently the 
number of local, state and federal institutions involved in HIV prevention planning runs into 
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the double digits. Furthermore, in establishing a training program to assist Russian health 
professionals and others involved in HIV prevention among IDUs, Burrows and colleagues 
(1999) observed a highly competitive atmosphere among (government) health agencies 
involved in this area. Absence of inter-agency collaborations and of information sharing 
within and between agencies seemed to be the usual modus operandi. They linked this 
situation to the scarcity of funds, but such a culture of secrecy and competition is of course a 
remnant of the communist past as well. As one Lithuanian narcologist explained: “Why would 
you share information or your ideas about a certain matter? It could only be used against 
you.”  
 Absence of sufficient funding is nonetheless a genuine issue. Salaries of health and 
other government workers (e.g., militia) are often months behind, buildings are in poor shape 
and funds for equipment, medications and professional literature are often lacking. In one 
regional AIDS center in the south of Russia the library was filled with the dust-covered 
complete works of Lenin and Stalin. Russian or international professional literature was 
nearly absent.  
 Another serious problem is the absence of a positive NGO climate, in particular in the 
NIS, but for example in Slovakia as well. Not only are NGO legislation and regulation often 
unnecessary complicated, but many state health workers consider NGOs with Argus’ eyes, 
that is, as a new set of competitors in a shrinking market. To make matters more complex, 
while “real NGOs” certainly exist in the HIV/AIDS field, many are closely linked to 
government institutions. In the previously mentioned evaluation study of Russian needle 
exchange programs, three out of five of the programs were administered by NGOs that were 
run by the head physician and core staff of the AIDS center, and all three were located at the 
premises of the AIDS center. The primary function of this type of NGO seems to be 
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attracting and channeling non-governmental and foreign funding. It also provides AIDS 
center staff a chance to be innovative and operate outside the rigid structures that determine 
their usual work (Burrows et al. 1999). And, last but not least, it offers a possibility to boost 
their regular (devaluated ruble) salaries with hard currencies, such as US dollars. Some of 
these initiatives have built impressive (peer/outreach-based) needle exchange projects, but 
elsewhere middle-aged epidemiologists and laboratory workers in white coats have taken up 
the outreach profession.  
A problem of a different order is that in most countries in the region, policy makers 
and professionals alike seem to believe that the situation in their country is not comparable to 
any other place in the world. “My country is different,” is a mantra that many foreign 
consultants have heard over and over again, where “my country” can be substituted by “our 
mindset,” “our drug users’ mentality” and other variants. Burrows and colleagues (1999) 
refer to this phenomenon as “Russianness,” but this author has been exposed to it in at least 
ten countries in the region, and elsewhere as well. The upshot of such remarks is generally 
that pragmatic interventions for IDUs tried successfully elsewhere will not work in the 
country. Perhaps associated to the cold war, such beliefs go hand in hand with a mistrust of 
“western” research and approaches, and with this comes a moral dismissal of many aspects of 
what UNAIDS terms “Best Practice” (UNAIDS 1999). The explicit ban on the use of 
methadone in the new Russian drug law serves as an apt example.  
 Particularly strong are misconceptions of drug users and their ability to adjust their 
behaviors, which are embedded in obsolete and unscientific ideas on the dynamics of drug 
use, addiction and the careers of drug users. Many narcologists and psychiatrists were trained 
to believe that, after their first injection, IDUs have on average three to four years to live, and 
that drug users are “hopeless” cases, who do not care whether they live or die (Burrows et al. 
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1999). When the prevailing sense is that drug users are not interested in protecting 
themselves and their family and friends against HIV, pragmatic, unmoralistic prevention 
becomes a hard sell. Along with these ideas comes an unwarranted belief in repressive 
approaches and mandatory treatment—hence the emphasis on mass screening, contact tracing 
and regular mandatory reporting.  
 
In areas such as drugs, prostitution and infectious diseases the health and law 
enforcement structures (Internal Affairs) have traditionally maintained fairly cooperative 
relationships in the Soviet Union and its successor states. As the director of the AIDS center 
in a large city east of Moscow explained, “The police have some same points of interest and 
same directions of work.” In particular “Narcology” maintained close ties with law 
enforcement—according to Burrows and colleagues (1999), Narcology in Russia was until 
the 1990s largely an instrument of Internal Affairs. A psychologist of a narcological center in 
the south of Russia put it in plain terms: “The relations with the police are good, they do a lot 
of mutual work.” Indeed, in the early stages of the epidemics in many cities in Russia, 
Ukraine, Belarus and other countries in the region drug users (and prostitutes) have been 
rounded up by militia and mandatory tested at the nearest AIDS center.  
 One can certainly find “enlightened” police officials in the region, who have more 
thoughtful ideas on drug use and HIV, especially outside of the capitals (and political 
spotlight)—in Ukraine, one of the first needle exchanges was initiated by (among others) a 
militia major. But, overall the position of Internal Affairs towards innovative HIV prevention 
programs, such as needle exchange has been highly censorious (Medecins Sans Frontieres-
Holland 1999). The first two needle exchange programs in Russia (St. Petersburg and 
Yaroslavl) were closely monitored and frequently hassled by Internal Affairs (Medecins Sans 
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Frontieres-Holland 1999; Sergeyev et al. 1999). Sergeyev and colleagues (1999) quoted a 
Russian national newspaper to illustrate the activities of Internal Affairs in the city of 
Yaroslavl: 
“For two weeks Drug Enforcement Officers have been watching closely the gray 
van running around Yaroslavl and attracting local drug users. The attention of 
police officers is focused on the needle exchange facility inside the van. The 
police are taking notice of every client attending the needle exchange so that 
their officers can report about the victories in the fight against drugs later on.” 
Perhaps because the St. Petersburg and Yaroslavl programs took a lot of the political heat, 
most of the more recently initiated needle exchange programs in Russia have some sort of 
agreement in place with the locally active branches of Internal Affairs. Outside of the 
political spotlight, at the oblast and city levels, the authorities have more autonomy and they 
seem simply less dogmatic and sensitive to pragmatic considerations. However, while police 
officials in the region are politically less dependent on Moscow and have some room for 
creative interpretation, they cannot totally ignore the federal (drug) laws or the views of the 
Ministry of Internal Affairs. As the head physician of an AIDS center which started needle 
exchange in the south of Russia explained:  
“The city and oblast police departments … approve of the program activities. But the 
drug legislation is repressive. It is necessary to change it. Now the attitude of the 
Ministry of Internal Affairs toward such programs is negative. That’s why it is 
difficult to work with police at the exchange sites.”  
Thus, agreements with one (of the several) police department(s) do not preclude the negative 
influence of Internal Affairs on IDUs’ participation in needle exchange and other HIV 
prevention programs.  
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 Furthermore, street militia is not always aware of these agreements and continues to 
hassle drug users around needle exchange programs. In the previously mentioned multi-city 
evaluation of needle exchange, 44% of respondents mentioned being harassed by the police 
or militia because they were suspected of carrying needles. Of those, 74% mentioned that 
they were verbally abused or threatened, while 59% said they were physically abused or 
pushed and shoved around. Another 59% said they were detained and 67% mentioned that 
the police had confiscated their injecting equipment, while 44% was forced to destroy or 
dispose of injecting equipment in front of the officer. That such treatment negatively 
influences program participation seems self-evident, as 40% of the respondents said that they 
normally do not carry injection equipment at all. Of those 58% explained that they feared 
discovery by the police as the reason for not doing so.  
 Thus, IDUs may run serious immediate risks (police hassling and brutality, arrest and 
subsequent withdrawal) by participating in an intervention, which helps them avert risks, 
which only matter in the long term. Under such conditions, visiting the needle exchange may 
score higher on the IDUs’ “Hierarchy of Risk” (Connors 1992) than averting some unclear 
infection (note that at present only few infected drug users in central and eastern Europe have 
developed clinical manifestations).  
 A related matter seriously troubling the development of adequate responses to the 
HIV epidemic in the region is the recent passing of increasingly repressive drug legislation. 
In April 1998 the Russian Duma passed a new, very repressive drug law, under which 
substitution treatment of opiate addiction with methadone is forbidden, while syringe 
exchange and other HIV prevention activities might be interpreted as abetting to drug use. 
Soon after president Yeltsin signed the law, police harassment of the St. Petersburg and 
Yaroslavl needle exchange programs increased. In Yaroslavl the needle exchange operation 
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closed its doors for two months for fear it was in violation of the new law, and in June 1998 
the police tried to close down the St. Petersburg project. In the following excerpt from an 
email, the program’s co-director from Medecins Du Monde described the situation: 
“News from the front. The bus has trouble with the police again. They are trying 
to stop it and for a while the bus is staying day and night in Pravoberejniy Rynok. 
The threat is that if the bus moves the police will take away all the driver’s 
licenses. For several days now, the bus has stayed put and the staff is sleeping in 
it to avoid problems.” (B. Stambul, e-mail June 29, 1998) 
Several other countries in the region have recently introduced more repressive drug 
legislation as well, among them the Czech Republic (1998), Poland (1997) and Hungary 
(1999). The Slovak Republic stiffened up drug laws as early as 1993. The most important 
difference with previous legislation is that all these new laws make possession of drugs a 
criminal act, although both the Polish and Czech laws made exceptions for possession of 
small quantities, treating those as a misdemeanor (Grund 1998b).  
 While human rights concerns—the proposed legislation punishes the victims rather 
than the perpetrator—prompted Czech president Vaclav Havel to veto these legislative 
proposals, this veto was overturned by an ad-hoc majority in parliament, which included 
Communists and Christian Democrats (Jakl 1998). What’s more, on November 17, 2000 
Polish President Aleksander Kwasniewski approved an even tougher anti-narcotics bill, 
which banned the possession of even small amounts of drugs and introduced compulsory 
treatment. Two days later, a senior official from the Country Planning and Programme 
Development section of UNAIDS sent the following reaction to the e-mail listserver of the 
CEE Harm Reduction Network: 
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“If [this new law] is properly reinforced it may isolate drug users from the 
service providers, with the well known consequences. We had such an example in 
one city of the region in 1996. At the end of that year the police made intensive 
raids on the apartments where traditionally built small groups of drug 
users/friends met to prepare and inject drugs. Following these raids, the groups 
reshuffled, mixing the members of different groups and the demand for ready 
solution prepared elsewhere grew up. This was considered at least one of the 
reasons that at the beginning of the next year the HIV epidemic blew up among 
IDUs in that city.” (L. Khodakevich, e-mail, November 19, 2000) 
UNAIDS has played an important role in developing a response to the HIV epidemics in this 
region. However, it has had great difficulties convincing another—for this effort crucial—UN 
agency, the United Nations Drug Control Program (UNDCP) of the necessity of harm 
reduction approaches to HIV prevention among IDUs, and, until very recently, this UN 
agency has not been involved in the “Joint United Nations Program.” For years UNDCP has 
been promoting repressive drug legislation in the region, opposing methadone, needle 
exchange and other harm reduction interventions. ” With the recent establishment of a new 
UNAIDS office in Vienna, next to the UNDCP headquarters, this will hopefully change. 
Nevertheless, this contradiction within the UN system illustrates perhaps the most essential 
problem in policy making for HIV prevention among IDUs: the fundamentally different goals 
and interests of the international struggle against HIV/AIDS and the globalized war on drugs. 
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Colliding International Concerns: Drugs, AIDS and Human Rights 
 Because such measures counter marginalization, and thus vulnerability to HIV, 
UNAIDS stresses that “[p]romoting human rights and tolerance is … important in fighting 
AIDS as well as in its own right” (UNAIDS 2000h). Its June 2000 Report on the Global 
HIV/AIDS Epidemic reads that “[m]any factors in vulnerability—the root causes of the 
epidemic—can best be understood within the universal principles of human rights.” The 
report continues with pointing towards a number of factors that engender vulnerability to 
HIV/AIDS. These include lack of respect for “freedom of expression and association,” “the 
rights to liberty and security,” “freedom from inhuman or degrading treatment,” and “the 
right to privacy and confidentiality” (UNAIDS 2000h). When it comes to drug users just 
about all of these rights are severely compromised in most countries in this region. 
Participants of focus groups of drug users in the previously mentioned multi-site needle 
exchange evaluation in Russia told many stories of police abuse. They maintained that the 
police persecute drug users with HIV/AIDS. They thought that the police still have the idea 
that the only way to stop the epidemic is by isolation of all infected people. One of the 
respondents told his story: 
“On April 30 I came out of the prison for HIV positives and was stopped 3 times 
by the police in the following 9 days. I have to report 2 times a month to the 
police. Three different police departments can come into my home whenever they 
want. I think the police hounds us because we are HIV positive.”  
Historically, this region does not have a good reputation for championing human rights, and 
focus group participants were well aware of their marginalized situation. They felt that civil 
rights are meaningless to them: “What human rights?” said one of them, while rubbing his 
fingers, “No money; no human rights! Ta ta!” 
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 UNAIDS insists that successful interventions can only develop when partnerships are 
created, and communities—including the drug user community—are taken into trust and not 
confronted (UNAIDS 1999). Nonetheless, the dominant approach towards the community hit 
hardest by the HIV epidemic in this region (and elsewhere) is rooted in a mixture of 
repression and grave disrespect for human rights.  
 The combustible properties of this mixture are likely to be exacerbated by yet another 
volatile ingredient: the treatment of ethnic minority communities. For example, the recent 
HIV outbreak (and drug injecting in  general) in Narva Estonia mainly concerns IDUs from 
the Russian minority in the city. However, in particular the stateless Roma, which are present 
in almost every corner of the region may be hit hard by the epidemic in the near future. A 
recent study reported a number of unsettling findings. In many cities across the region a 
substantial proportion of the Roma community is involved in drug injecting. The overall 
prevalence of injection drug use in these cities equals or greatly exceeds those known in 
Western Europe and other established market economies. However, proportionally, injection 
drug use seems to have touched the Roma community in these cities to a much greater (2 to 
20 times) extent. Thus, in Vilnius, the capital of Lithuania, reportedly 0.3 to 0.5% of the 
overall population are drug injectors, while the prevalence of drug injecting in the local Roma 
community is estimated at 6 to 10% (Grund et al. 2000). The problems seem to concentrate in 
one Roma tabor (settlement) on the edge of town, where some 50 out of approximately 250 
residents are drug injectors (Subata and Tsukanov 1999), while Roma living in the city—who 
are more “integrated” and economically better off—seem less affected. Likewise, in Szeged 
in southern Hungary, the overall prevalence is reportedly slightly less than one percent, but 
among the local Roma it is 5 to 7%.  In all, 80 out of 200 participants of the local peer-
outreach-based syringe exchange are Roma IDUs (Grund et al 2000).  
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 Heroin use is rapidly gaining popularity among Roma youth and reportedly they start 
injecting at a very early age. The study points towards many factors that suggest an increased 
vulnerability of the Roma for HIV infection. These include increased levels of HIV risk 
behaviors among Roma IDUs, barriers to clean needles and other HIV prevention services 
(HIV testing and education; drug treatment), as well as social-economic matters, such as the 
community’s structural exclusion from the mainstream economy. HIV prevention or drug 
treatment projects targeting drug users in this minority community are virtually absent.  
 Throughout the region, Roma are considered to be an undesirable underclass and they 
are still heavily discriminated on the labor market, in the educational system, in health care 
and in many other services. Given their structural exclusion from the mainstream economy 
and historical reliance on the “shadow economy” for their sustenance, it should not come as a 
surprise that Roma communities in many parts of the region are reportedly involved in 
supplying heroin and other drugs. Thus, Subata and Tsukanov (1999) reported that about 
70% of the production of opiates from poppy straw in the region takes place in the mentioned 
Roma tabor. In all five cities in the Russian needle exchange evaluation study, the local 
Roma population was reportedly the main source of opiates and other drugs, while in 
Bratislava consumption level heroin dealing is dominated by Roma as well. 
 Against the background of a mounting drug war atmosphere in the region, their 
involvement in drugs is likely to pose a genuine threat to both their already compromised 
health status and the historically delicate human rights situation of the Roma communities in 
the region at large. It is not undue to expect that the police will increasingly target the Roma 
community under the pretext of the fight against drug dealers, in particular under the new 
repressive drug legislation. Furthermore, law enforcement targeting Roma drug users and 
dealers may implicitly or explicitly, and perhaps even deliberately, foster the impression that 
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the drug problem and Roma are synonymous and that Roma are to blame as perpetrators 
rather than to commiserate with as victims. Both the World Bank and UNAIDS have warned 
that the more marginalized and oppressed minority populations are, the more vulnerable they 
become to HIV epidemics. Hopefully, the sketched scenario will not become a case study of 
this important observation. 
 
Glimmers of Hope? 
 The picture sketched in this chapter does not evoke a lot of confidence in the 
possibilities of developing appropriate and timely responses to HIV in the region. Reading 
the December 2000 AIDS epidemic update, jointly issued by UNAIDS and WHO and 
providing a global summary of the HIV/AIDS epidemic up to that moment (UNAIDS/WHO 
2000b), one gets the impression that the epidemiologists at UNAIDS and WHO share much 
of this pessimism (UNAIDS/WHO 2000b).  
 
Despite this grim picture, there are signs that a response is developing in the region. 
Because of the large number of countries in this region it is nearly impossible to outline 
country-specific responses in this chapter. Therefore, the following section does not pretend 
to provide a comprehensive overview of policy and project development in central and 
eastern Europe, but merely discusses some interesting developments.  
 At the level of policy development, UNAIDS, WHO and other UN agencies, as well 
as international organizations, such as Medecins Sans Frontieres (MSF), Medecins Du 
Monde (MDM) and the Lindesmith Center, a project of financier George Soros’ Open 
Society Institute (TLC/OSI) have played a leading role in developing the initial response.  
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UNAIDS, WHO and other UN agencies have invested much time and energy in supporting 
national governments develop integrated “multisectoral and multilevel” approaches 
(UNAIDS 2000h). It seems that this onerous exercise is starting to yield rewards in some 
countries. For example, despite its Soviet bureaucratic tradition, in Belarus practically all 
ministries and state committees are involved in the response to HIV, which includes harm 
reduction interventions for IDUs and awareness-raising campaigns conducted by the national 
railways (UNAIDS/WHO 2000a). Reliance on obsolete mass screening techniques is 
reportedly decreasing in many countries and substituted by more intelligent HIV sentinel 
surveillance and education of the population. In 1998, Ukraine passed legislation, embracing 
a modern public health-based philosophy towards controlling its HIV epidemic. Among other 
positive changes, the country stopped compulsory screening of inmates and isolating those 
found HIV-positive, and, instead, started prevention programs in the prisons. Voluntary drug 
treatment is also developing in the country, and steps have been taken toward the introduction 
of methadone maintenance treatment for opiate addicts. 
In Russia, Medecins Sans Frontieres-Holland has developed an intensive training 
project on HIV prevention among IDUs for health care providers and others working on HIV 
prevention. Between January 1998 and February 1999, the project trained 200 people from 61 
Russian cities (U. Weber, personal communication, Burrows et al. 1999). The program is 
developed in consultation with the ministry of health and part of a strategic alliance with 
Medecins Du Monde and the International Harm Reduction Development program (IHRD) of 
the Lindesmith Center/Open Society Institute. This alliance, the Russian AIDS Prevention 
Initiative-Drugs (RAPID) is unique in the world in the sense that following the training, 
successful trainees are supported in applying for funding at a grants program funded by 
IHRD and OSI Russia. Thus, it includes intensive initial training, support with project 
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formulation and budget development—which are new concepts—and project funding, 
including further technical assistance. Until today, IHRD has funded more than 150 harm 
reduction programs, including needle exchanges and methadone maintenance programs. 
These projects are not only in Russia, but throughout the region, in both areas that reported 
significant outbreaks of HIV in IDUs and in low prevalence areas.  
 With its growing magnitude, a realization grows that drastic, unconventional and 
innovative measures are required to counter and control the HIV epidemic. Research from 
around the world has built strong scientific case for harm reduction approaches (Des Jarlais 
1995; Drucker 1995) and after initial—largely ideological—resistance support for this 
comprehensive approach is rapidly in central and eastern Europe, as well as in the central 
Asian countries. Strengthened by the support of fortunately an increasing number of other 
international (donor) organizations, researchers, activists and professionals in the region have 
started to develop a wide range of harm reduction projects. An equally important 
development is the development of networks in the region, such as the Central Eastern 
European Harm Reduction Network, the South East European Harm Reduction Coalition and 
the recently established Central Asian Harm Reduction Network. These, often internet-based, 
networks are a definitive departure with the old culture of secrecy and competition and they 
connect scientists, professionals and activists not only within the region, but also to the 
international drugs and AIDS community.  
 While the HIV epidemic is getting out of control in Russia, the overall number of new 
infections in Ukraine and Belarus seems to have decreased. While these results received both 
UNAIDS praise and extensive media coverage, another, possibly more significant, result just 
across the border in Lithuania caught less attention. Perhaps because until now a large 
outbreak has not yet occurred in the country. According to the Lithuanian AIDS Center, early 
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prevention programs have helped Lithuania—which shares borders with HIV epicenters 
Poland, Belarus and Russia's Kaliningrad region—keep its HIV infection rate the lowest in 
central Europe, at 6.8 cases per 100,000 people. A total of 257 HIV cases have been recorded 
in Lithuania, including 56 new infections reported so far this year (Anonymous 2000). 
Lithuania belongs to the few countries where before rapid HIV spread among IDUs was 
reported, concerned clinicians, activists (e.g., parents of drug users) and policy makers 
worked together in implementing “best practice” or proven harm reduction interventions. The 
country largely abandoned the soviet narcology system, and has developed perhaps the most 
pragmatic government guidelines on methadone (maintenance) treatment in the region. 
Likewise, needle exchange, outreach and peer strategies were timely introduced, giving the 
country, compared to its neighbors, a headstart in contacting and educating out-of-treatment 
drug users about HIV.  
It remains to be seen whether the country can maintain its low infection rate, as harm 
reduction services for IDUs are not present in all cities and such services must compete for 
scarce funds with primary drug prevention programs and low-volume, high-threshold drug 
treatment programs. As the director of the Vilnius Substance Abuse Treatment Center 
contended:  
“Definitely, the low HIV prevalence is not due to primary drug prevention or 
the twelve treatment slots in [the country’s] therapeutic community. On the 
other hand I am not sure that there is no potential "Narva" in one of the 
industrial cities in Lithuania, which have no methadone maintenance treatment 
and needle exchange programs for IDUs. No services, no IDUs reached, no 
HIV positives. Just as three months ago in the Estonian city of Narva” (E. 
Subata, Personal Communication). 
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CONCLUSION 
 This chapter described the HIV epidemic in central and eastern Europe. Based on a 
review of the epidemiological evidence, we can conclude that, more than anywhere else, the 
rapid pace of HIV spread is fueled by illicit drug injection. The examination the injecting 
drug use patterns prevalent in the region suggested that the characteristic social setting of 
drug injecting (group use) might have facilitated rapid spread within this population. 
Likewise, the widespread nature and relatively high level of community tolerance of drug 
injecting may set the stage for a rapid secondary diffusion into the general population by way 
of sexual transmission.  
 In some parts of the region the responsiveness of politicians and bureaucrats to the 
epidemic seems to have improved and a number of innovative HIV prevention projects have 
been established. Nevertheless, the overall conclusion must be that the response to the 
epidemic has developed at a pace too slow to control further spread. The chapter described 
several (socio-cultural and political) obstacles from which this slow development resulted. 
Many of these are associated with the slow transition away from totalitarianism.  
 How the response to HIV in the region further progresses may depend very much on 
the developments in Russia. Having been educated within the soviet system, policy makers 
and professionals in leading positions throughout the region are confused about how to 
address the drug injecting-driven HIV epidemic, and many, in particular in the central Asian 
successor states of the FSU, are looking towards Moscow for guidance and leadership. 
Russia’s emphasis on the allegedly unique features of its culture and the resulting dismissal 
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of “best practice” is in this context an important impediment to controlling the epidemic in 
the whole region. Of course, the design of appropriate interventions must include a cultural 
sensitivity to the particularities of each culture facing the epidemic. However, the 
international experience teaches that certain best practice interventions can transcend such 
cultural specificity. A lackluster response of archaic bureaucratic structures can therefore not 
be hidden behind a front of “Russianness” or its regional variations. 
 In particular, the vulnerable position of drug users is of great concern: intense 
repression of drug users has alienated them from the public health system to a great extent. 
This outcome is associated with the dominant influence of Internal Affairs in matters of 
public health. Not only are ministries of internal affairs vocal opponents of needle exchange, 
methadone treatment and other examples of “best practice,” their repressive approach to drug 
users is a main obstacle to the region’s struggle against HIV/AIDS, and brings about serious 
human rights concerns. While the experience elsewhere shows that good collaborative 
relationships between public health and law enforcement structures are important for 
developing successful interventions, such collaborations ought not to be determined by a law 
enforcement agenda, but by the requirements of an efficient public health-based response to 
the virus.  
 An additional worry is the influx of highly stigmatized ethnic minorities into the drug 
injecting population, such as the Roma. This trend is expected to result in rapid HIV spread in 
these communities and further complicate the human rights aspects of the epidemic, as they 
may easily become scapegoats for the failures of the authorities in controlling the twin 
epidemics of drug injecting and HIV.  
 The recent introduction of more repressive drug laws in several countries suggests 
that joining the international war on drugs may seem attractive to governments of countries 
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where the legacy of communist bureaucracy is still tangible in many areas of public policy 
making. Referring to its negative consequences, including HIV/AIDS, George Soros wrote 
that US drug policy “offers a prime example of adverse, unintended consequences.” He 
argued that “there is perhaps no other field where our public policies have produces an 
outcome so profoundly at odds with what was intended” (Soros 1997). The US drug war has 
facilitated the spread of disease (Grund et al. 1992), and its opposition to harm reduction 
measures, such as needle exchange has resulted in extensive human and economic loss (Lurie 
and Drucker 1997). Embarking on an US-style drug war would further compromise the 
region’s response to HIV. One should not forget that, from a biological viewpoint, the 
struggle against HIV/AIDS is an inter-species battle, while the drug war has become an intra-
species conflict. 
 It may perhaps nowhere else become more obvious than in central and eastern 
Europe, and in particular in the FSU, how from a public health perspective, the HIV epidemic 
among drug injectors has become a sentinel measurement for assessing the success of our 
drug policies. With up to 90% injecting drug users among the region’s registered HIV cases, 
the region can simply not afford for its leaders to jump on the bandwagon of the drug war. 
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i Narcology is a medical specialization, usually held by psychiatrists, though narcology staff also tends 
to include psychologists. Prior to 1991, when drug use was decriminalized in Russia (which was undone again 
in 1998), (alcohol and) drug treatment was punitive and draconian, involving prison sentences, labor camps and 
specialized correctional centers, based on medical, moral and Pavlonian treatment models. Confidential 
treatment was non-existent. Nowadays, narcology staff performs many of the functions of drug and alcohol 
workers in western countries including efforts to prevent drug use, assessment for treatment and detoxification. 
Detoxification is provided at narcological hospitals, and is normally supported by medication, but this seems to 
depend on whether the patient can afford those. Medications appear to be mainly Russian-made variations of 
minor tranquilizers and analgesics. Present detoxification treatment models vary widely, and include Western-
style (psychological) individual and group counseling, but also neural surgery, hyperthermic heating of the 
blood, aromatherapy, coma therapy, and music therapy. The exact methodology seems to depend on the ideas 
and beliefs of the most senior local narcologist). While more patient/client-centered treatment approaches are 
being introduced, in many places treatment assessment continues to be an involuntary practice in many cases, as 
clients are often brought to the clinic by police or parents. Detoxification is often undergone under pressure 
from families and, once a detoxification center is entered, clients are usually locked in and cannot leave. Only 
limited post-detoxification treatment is available, usually involving counseling. Residential rehabilitation is still 
rare and usually run by NGOs, which contract narcologists as consultants (Burrows, Personal Communication; 
Green et al. 2000). 
